Brief: Gritstone bio Announces Update to Comparative Phase 2b COVID-19 Clinical Trial
12/02/2024 12:39
Feb 12 (Reuters) - Gritstone bio Inc GRTS.O :
* GRITSTONE BIO ANNOUNCES UPDATE TO COMPARATIVE PHASE 2B
COVID-19
CLINICAL TRIAL
* GRITSTONE BIO INC: NOW PREPARING TO LAUNCH PHASE 2B
HEAD-TO-HEAD
TRIAL OF ITS NEXT-GENERATION COVID-19 VACCINE IN FALL OF 2024
RATHER THAN 1Q24
Source text for Eikon: ID:nGNX7YhSfY
Further company coverage: GRTS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Gritstone bio
See all newsBrief: Gritstone Bio Inc On Dec 31 2024, Vassiliki “Celia” Economides Became Interim CEO As Well As CFO Of Co
Brief: Gritstone Bio Announces Strengthening Of Maturing Phase 2 PFS Data for GRANITE Study And Provides Business Update
U.S. STOCKS ON THE MOVE-Avery Dennison, Snap-On, Avadel Pharma
U.S. STOCKS ON THE MOVE-Avery Dennison, Snap-On, Avadel Pharma
U.S. STOCKS ON THE MOVE-PPG Industries, Travelers, ShiftPixy